Leukemia/Lymphoma News
Seattle Genetics Reports Data from Phase I Trial of ADCETRIS® (Brentuximab Vedotin) in Front-line Ma
Cancer treatment 'blows tumours away in weeks'
Seattle Genetics Announces Antibody-Drug Conjugate Collaboration With Millennium